Howe & Rusling’s Bausch Health BHC Stock Holding History

Howe & Rusling’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100	Closed	-$1K	–	397
2022 Q3	$1K	Hold	100	–	–	﹤0.01%	937
2022 Q2	$1K	Hold	100	–	–	﹤0.01%	928
2022 Q1	$2K	Hold	100	–	–	﹤0.01%	838
2021 Q4	$3K	Sell	100 -818	-89%	-$21.9K	﹤0.01%	785
2021 Q3	$26K	Buy	918 +168	+22%	+$4.76K	﹤0.01%	377
2021 Q2	$22K	Sell	750 -3,290	-81%	-$99.7K	﹤0.01%	386
2021 Q1	$128K	Hold	4,040	–	–	0.02%	210
2020 Q4	$84K	Buy	+4,040	New	+$75.4K	0.01%	239
2018 Q3	–	Sell	-5	Closed	–	–	856
2018 Q2	$0	Hold	5	–	–	﹤0.01%	828
2018 Q1	$0	Sell	5 -295	-98%	-$5.49K	﹤0.01%	945
2017 Q4	$6K	Hold	300	–	–	﹤0.01%	525
2017 Q3	$4K	Hold	300	–	–	﹤0.01%	605
2017 Q2	$5K	Hold	300	–	–	﹤0.01%	618
2017 Q1	$3K	Hold	300	–	–	﹤0.01%	738
2016 Q4	$4K	Hold	300	–	–	﹤0.01%	706
2016 Q3	$7K	Hold	300	–	–	﹤0.01%	583
2016 Q2	$6K	Hold	300	–	–	﹤0.01%	569
2016 Q1	$8K	Hold	300	–	–	﹤0.01%	567
2015 Q4	$30K	Buy	300 +295	+5,900%	+$33.1K	0.01%	323
2015 Q3	$1K	Hold	5	–	–	﹤0.01%	896
2015 Q2	$1K	Hold	5	–	–	﹤0.01%	934
2015 Q1	$1K	Buy	+5	New	+$887	﹤0.01%	837

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Howe & Rusling's BHC Position: Q4 2022 in Review

Howe & Rusling sold out of Bausch Health (BHC) in Q4 2022, closing a stake of 100 shares — an estimated $1K sold.

Howe & Rusling first reported a position in BHC in Q1 2015 and held it in 22 quarters. The position peaked at $128K in Q1 2021. 262 funds tracked by Wall St. Rank hold BHC as of Q4 2022.

Howe & Rusling reported no remaining Bausch Health position as of Q4 2022 after selling out during the quarter.
Howe & Rusling sold 100 Bausch Health shares in Q4 2022, an estimated $1K.
Howe & Rusling first reported a position in Bausch Health in Q1 2015 and held it in 22 quarters.
Howe & Rusling's Bausch Health position peaked at $128K in Q1 2021.
262 funds tracked by Wall St. Rank held Bausch Health as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.